NCT02557984View on ClinicalTrials.gov

Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Addiction
Interventions
DRUG

Placebo

Placebo Pill

DRUG

Amisulpride

400 mg Amisulpride

DRUG

Naltrexone

50 mg Naltrexone

Trial Locations (1)

8091

University Hospital, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT02557984 - Dopamine and Opioid Receptor Antagonists Reduce Cue-induced Reward Responding and Reward Impulsivity | Biotech Hunter | Biotech Hunter